Firefly Neuroscience (AIFF) Capital Expenditures (2010 - 2026)

Firefly Neuroscience's Capital Expenditures history runs 16 years deep, the most recent figure standing at $58000.0 for Q1 2026.

• On a quarterly basis, Capital Expenditures rose 728.57% year-over-year to $58000.0 in Q1 2026; TTM through Mar 2026 was $179000.0, a 28.78% increase from a year earlier, with the FY2025 full-year figure at $128000.0, down 13.51% from the prior year.
• Capital Expenditures improved to $58000.0 in Q1 2026 per AIFF's latest filing, from $23000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $301842.0 in Q4 2022 and bottomed at $7000.0 in Q1 2025.
• The 4-year median for Capital Expenditures is $58000.0 (2026), against an average of $77627.5.
• Across the five-year window, Capital Expenditures surged 2096.17% in 2022 and tumbled 81.25% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $301842.0 in 2022, then plunged by 77.47% to $68000.0 in 2024, then plunged by 66.18% to $23000.0 in 2025, then surged by 152.17% to $58000.0 in 2026.
• Per Business Quant, the three latest AIFF Capital Expenditures figures stand at $58000.0 (Q1 2026), $23000.0 (Q4 2025), and $86000.0 (Q3 2025).